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ABSTRACT 
The long-term relationship between the general economy and healthcare expenditures has 
been extensively researched, to explain differences in healthcare spending between countries, 
but the mid-term (i.e., business-cycle) perspective has been overlooked. This study explores 
business-cycle sensitivity in both public and private parts of the healthcare sector across 32 
countries. Responses to the business cycle vary notably, both across spending sources and 
across countries. Whereas in some countries, consumers and/or governments cut back, in 
others, private and/or public healthcare buyers tend to spend more. We also asses long-term 
consequences of business-cycle sensitivity, and show that public cost cutting during economic 
downturns deflates the mortality rates, whereas private cut backs increase the long-term 
growth in total healthcare expenditures. Finally, multiple factors help explain variability in 
cyclical sensitivity. Private cost cuts during economic downturns are smaller in countries with 
a predominantly publicly funded healthcare system and more preventive public activities. 
Public cut backs during contractions are smaller in countries that rely more on tax-based 
resources rather than social health insurances.  
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1. INTRODUCTION 
Because of its huge social and economic importance, the healthcare sector receives a lot of 
research attention. Among the biggest concerns in this field are exploding healthcare 
expenditures, which tie up funds that could be used for other purposes or increase debt levels. 
Although higher healthcare expenditures can reduce a country’s mortality rate, nations 
struggle to keep healthcare expenditures under control; they have outpaced the growth of the 
general economies of most Western countries in recent decades (Mladovsky et al. 2012).1 
The (long-run) relationship between healthcare expenditures and the general economy 
has been studied extensively in an attempt to explain differences across countries in their 
healthcare spending levels and growth (for a review, see Gerdtham and Jönsson 2000). Yet a 
business-cycle (mid-term) perspective, may lead to substantially different conclusions about 
the link between the economy and healthcare, with important policy implications (Narayan 
and Narayan 2008). This perspective is lacking from extant research. 
Although, a priori, the healthcare industry may appear unrelated to temporary 
economic up- and downswings - people’s medical needs should not fluctuate with the 
business cycle - anecdotal evidence during the latest recession indicates otherwise. According 
to Deloitte’s 2011 Survey of Healthcare Consumers, about half of the respondents in all 
countries surveyed (except for Luxembourg) indicated that the economic downturn affected 
their willingness to spend on healthcare. In the UnitedStates, for example, 41% of respondents 
indicated that the poor economic climate made them more cautious about such spending. Yet, 
about half of all respondents worldwide (except for the United Kingdom, Canada, and China) 
                                                          
1
 Between 2009 and 2011, one-third of the OECD countries experienced negative growth in health care 
expenditures (OECD 2013). In our study 17 of the 32 countries exhibit at least one year in which their total 
healthcare expenditures dropped between 2009 and 2011. Yet, for 13 of these 17 countries, the drop was 
temporary and linked to the business cycle, whereas the long-term trends remained positive. We observe 
decreases in both the cyclical and the long-term components of healthcare expenditures only in Greece, Iceland, 
Ireland and Luxembourg. To test if these examples represent a permanent phenomenon, we would require 
sufficient observations after the economic slowdown, which are not yet available. 
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noted increased household spending on healthcare during the global recession, possibly 
because economic downturns can harm people’s mental health, due to their increased anxiety 
about losing their jobs, or about the future in general (Tefft 2011). Nonetheless, Ruhm (2003) 
demonstrates that mortality rates typically are lower during tough economic times.  
In terms of public spending, we can also observe varying responses to the latest 
economic crisis (Strine et al. 2008). The U.S. government introduced a $150 billion 
stimulation package for the healthcare industry as part of its Recovery and Reinvestment Act, 
and Norway has invested in reforming and improving its healthcare systems to avoid social 
inequalities. In contrast, countries such as Estonia, Ireland, and Iceland recently introduced 
big cuts in their public healthcare expenditures. Such anecdotal evidence in aggregate seems 
to imply that both private and public healthcare expenditures may be related to cyclical up- 
and down movements in the general economy (i.e., the business cycle), such that differences 
between countries and spending sources are likely.  
Beyond establishing a foundational insight, regarding whether healthcare spending is 
sensitive to the business cycle, policy makers also need to understand how these cyclical 
fluctuations affect the sector in the long run. When private healthcare buyers need to reduce 
their healthcare expenditures, they often do so in less immediately urgent areas, such as 
prevention programs and procedures that can be postponed (e.g., quit-smoking programs, 
diabetes and cancer prevention; Mladovsky et al. 2012). These decisions may help reduce 
healthcare expenditures during bad times, but failing to prevent or treat problems over time 
may have negative impacts on people’s long-term health status. Moreover, to restore their 
health status to the level they had before the crisis, people might need to overcompensate, 
which would entail a long-term impact in the form of rising healthcare expenditures.  
For public entities, cutting healthcare expenditures might not necessarily result in 
negative long-term consequences. Governmental cuts in healthcare expenditures are necessary 
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from time to time, to increase efficiency in the sector. Such moves likely are easier to justify 
when the overall economy turns sour (Lane 2003b), because an economic crisis signals an 
opportunity for innovation and new approaches to efficient healthcare that might not exist 
otherwise (Thorlby 2011). When these reforms lead to improved efficiency in the sector, the 
spending on healthcare may decrease in the long run, due to public budget cuts. In addition, 
mortality rates decrease during economic downturns (Ruhm 2000, 2003, 2005), which makes 
public budget cuts even more appropriate. For example, many Canadian provincial 
governments cut their health budgets following an economic crisis in the 1990s, while 
simultaneously implementing structural reform of the sector, which led to lower mortality 
rates over time (Liu et al. 2001).  
Finally, we need insights into which factors drive the cyclical sensitivity of healthcare 
expenditures. The healthcare system established by a country strongly determines its cost 
structure, and thus likely influences its cyclical sensitivity, for example. Public prevention 
spending also can promote healthcare usage through preventive activities, but the public debt 
level might decrease a country’s ability to act during an economic downturn.  
Considering these various factors and necessary insights, we seek to answer three key 
research questions:  
(i) Are private and public healthcare expenditures related to the business cycle?  
(ii) Does cyclical sensitivity have long-term consequences, in terms of the 
mortality rate of the population and total healthcare expenditures? 
(iii) Which factors explain across-country variability in cyclical sensitivity?  
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2. HEALTHCARE EXPENDITURES AND THE BUSINESS CYCLE 
An expansive body of research studies the relationship between healthcare expenditures and 
the general economy (gross domestic product [GDP]), in an attempt to explain cross-country 
differences (see Gerdtham and Jönsson (2000) for an overview of this literature).  
In a pioneering study, Newhouse (1977) identified a strong positive relationship 
between healthcare expenditures and GDP, using a cross-sectional analysis of 13 OECD 
countries. His results cited GDP as the most important driver of healthcare expenditures. 
When time-series data on healthcare expenditures become available in the 1990s, more 
sophisticated analyses appeared, exploring whether this positive relationship between 
healthcare expenditures and GDP held over time. Several studies tested for long-run 
relationships on a country-by-country basis (e.g., Herwartz and Theilen 2003) or across 
countries using panel data techniques (e.g., Gerdtham and Loethgren 2000; McCoskey and 
Selden 1998). Despite some debate (e.g., Hansen and King 1996), most studies indicate that 
healthcare expenditures and GDP are co-integrated (Blomqvist and Carter 1997; Gerdtham 
and Loethgren 2000; Herwartz and Theilen 2003), such that they co-move in the long run. 
Overall, general economic activity remains the most consistent and widely used predictor of 
over-time developments in healthcare expenditures (Di Matteo and Di Matteo 1998).  
The focus in most studies has been on the long-term relationship between the economy 
and healthcare expenditures, but some research also shows that interactions between the same 
variables can vary with different periodicities. For example, Baxter (1994) shows that the 
relationship between real exchange rates and real interest rate differentials does not exist in 
the short run (i.e., at high frequencies), but it is strong for both long-run and business-cycle 
(mid-run) periodicities. As the long-term relationship of healthcare expenditures and general 
economic activity does not necessarily translate in the same relationship at the business cycle 
perspective, more research is needed to determine the cyclical sensitivity of the sector.  
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A rich research stream, led by Ruhm (2000, 2003, 2005), already has established the 
importance of the business cycle perspective for healthcare researchers (see also Gerdtham 
and Ruhm 2006; Miller et al. 2009). However, this research stream focuses on the business 
cycle sensitivity of people’s health status or the mortality rate. To the best of our knowledge, 
no study has systematically analyzed the cyclical sensitivity of healthcare expenditures across 
a large sample of countries, as called for by Narayan and Narayan (2008).  
Furthermore, recent research proposes separate analyses of healthcare expenditures for 
private consumers and government entities, because it is not clear whether the two sources 
develop in similar ways (Getzen 2000). Clemente et al. (2004) suggest that the long-term 
relationship between the overall economy and private and public healthcare expenditures 
evolve differently over time. Disentangling the private from public expenditures thus may 
lead to a more fine-grained picture of the sector.  
Accordingly, we formulate several arguments about the likely direction of cyclical 
sensitivity of public and private expenditures. 
 
Public Expenditures. Economic contractions might lead to cost cuts, or procyclical 
fluctuations, in public healthcare expenditures, for two reasons. First, countries might face 
severe budget constraints due to tumbling revenues and thus be forced to reduce their 
expenditures in all sectors (Stuckler et al., 2009). Second, downturns can provide 
justifications for making cuts in socially important sectors. As Lane (2003b) indicates, it is 
much harder for governments to prevent expenditure growth during good economic times 
than during downturns. Different institutions are less demanding in budget negotiations 
during downturns, because everybody knows that the amount to be distributed is much 
smaller. However, some evidence also suggests the opposite reaction of increasing public 
expenditures during contractions, or countercyclical sensitivity. Countries often adopt a 
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classical Keynesian approach and try to stimulate the economy during tough times (Lane 
2003b). Government stimulation packages usually contain general investments in 
infrastructure or other institutions of common interest. Because healthcare has great social and 
economic importance, it is a useful target for such investments.  
  
Private Expenditures. Private expenditures also might relate to the business cycle.  On the 
one hand, private consumers economize on their spending in general during economic 
downturns (i.e., behave procyclically) (Katona 1974). In the healthcare sector, they buy more 
generic pharmaceuticals or postpone treatments with higher out-of-pocket payments to save 
money (Neumayer 2004). On the other hand, private expenditures could behave 
countercyclically, because economic downturns affect people’s mental health, in the form of 
increased anxiety about the future (McInerney and Mellor 2012). Therefore, they might 
increase their spending in the mental health sector. People who are at risk of losing their jobs 
also experience increased health risks (Deb et al. 2011; Tefft 2011). This group grows larger 
when the economy declines, so treatment costs may increase overall.  
  
Because these arguments suggest a wide range of possible outcomes with regard to the 
business-cycle sensitivity of public and private healthcare expenditures, we expect substantial 
cross-country variability in private and public cyclical sensitivities.  
 
Method 
We derive cyclical comovement elasticities, which quantify the cyclical sensitivity of public 
and private healthcare expenditures separately for each country under investigation. We first 
filter out fluctuations that correspond to business-cycle periodicities. Next, we relate cyclical 
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fluctuations in private (public) healthcare expenditures to those of the economy as a whole, 
which reveals the private (public) comovement elasticities.2  
Extracting the cyclical component. We use the well-known Hodrick and Prescott (HP) 
(1997) filter to extract the cyclical component from series of public and private healthcare 
expenditures (see Lamey et al. 2007 for a detailed review of the HP Filter). The HP filter 
decomposes a time series (ݕ௧) into a steadily evolving long-term trend component (ݕ௧௧௥௘௡ௗ) 
and a cyclical component (ݕ௧௖), which fluctuates around the long-term trend. Then it extracts 
the trend component ݕ௧௧௥௘௡ௗ of a time series by minimizing the following specification:
  
 
∑ ሺݕ௧ − ݕ௧௧௥௘௡ௗ௧்=ଵ ሻ² + λ ∑ ሺሺݕሺ௧+ଵሻ௧௥௘௡ௗ்−ଵ௧=ଶ −  ݕ௧௧௥௘௡ௗሻ − ሺݕ௧௧௥௘௡ௗ − ݕሺ௧−ଵሻ௧௥௘௡ௗሻሻ²  (1),
 
 
where T represents the number of years included in the time series. The first quadratic term is 
a goodness-of-fit measure; the second quadratic expression determines the smoothness of the 
trend component. The solution to specification (1) thus represents a trade-off between fit and 
smoothness, based on the smoothing parameter � (Hodrick and Prescott 1997). The larger the 
value of �, the smoother the trend component is. We set the smoothing parameter to equal 10, 
a value that produces a good correspondence between the HP filter and an ideal band-bass 
filter that passes through cycles between two an eight years (i.e., business-cycle periodicities) 
(Baxter and King 1999).  To obtain the cyclical component (ݕ௧௖), we remove the long-term 
component ሺݕ௧௧௥௘௡ௗሻ  from the original series ሺݕ௧ሻ: 
                                                          
2 A simultaneous derivation of the cyclical component of the time series and quantification of the comovement 
elasticity and/or long-run effects (Section 3) would be prohibitively complicated. In line with prior studies (e.g., 
Lamey et al. 2007, 2012; Steenkamp and Fang 2011) and for exposition, we use a multi-stage approach. An 
alternative might estimate a single, fully flexible (potentially non-linear) model, which would decrease the 
efficiency loss due to our multi-stage estimation.  
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     ݕ௧௖ = ݕ௧ − ݕ௧௧௥௘௡ௗ     (2). 
 
Because we are interested in the per-country sensitivity of public and private healthcare 
expenditures, we apply this procedure to the healthcare expenditures time series (ℎܿ݁�௦௧) of 
each country i, expenditure source s (i.e., public [pub] or private [pri]), and time period t to 
obtain the cyclical component ሺℎܿ݁�௦௧௖ ሻ.                                     
Relating the cyclical component to the business cycle. To measure the relationship 
between healthcare expenditures and the aggregate business cycle, we computed the cyclical 
comovement elasticity (see e.g. Lamey et al. 2007 for a similar practice). This comovement 
elasticity measures how cyclical fluctuations in the aggregate economy translate into cyclical 
fluctuations in private (public) healthcare expenditures. It is obtained by regressing the 
cyclical component of healthcare expenditures (ℎܿ݁�௦௧௖ ) on the cyclical component of GDP ሺ݃݀݌�௧௖ ) on a per-country base (see Equation 3). The cyclical component of GDP (݃݀݌�௧௖ ሻ, 
obtained via the HP-filter (following Equations 1 and 2), includes the business cycle 
fluctuations across many industries on a national level and is thus an appropriate indicator of 
the business cycle. Accordingly, 
 
    ℎܿ݁�௦௧௖ = ߚ�௦ ݃݀݌�௧௖ + ߝ�௦௧     (3). 
 
To enhance comparability, both series were log-transformed before filtering, to represent 
percentage deviations from a long-term trend. Therefore, ߚ�௦ can be interpreted as a 
comovement elasticity. The sign of the elasticity indicates whether a country’s public or 
private healthcare expenditures are procyclical (ߚ�௦> 0) (i.e., increase during expansions and 
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decrease during contractions) or countercyclical (ߚ�௦< 0) (i.e., decrease during expansions and 
increase during contractions). To control for potential autocorrelation, we allow for an auto-
regressive (AR) error term in Equation 3 (see Lamey et al. 2012). Whether an AR term is 
included depends on the Akaike information criterion. 
 
 Data 
The data set covers the public and private healthcare expenditures of 32 OECD countries 
between 1990 and 2011.3 To capture multiple business cycles, we selected all OECD 
countries with at least 13 subsequent observations within this time frame, producing an 
average of 20 subsequent observations per country (see e.g. Lamey et al., 2007 and van 
Heerde et al. 2013 for a similar practice). Table 1 contains an overview of our key measures. 
 
-- insert Table 1 about here-- 
 
Annual public and private healthcare expenditures, measured in national currency, 
came from the OECD’s Health Data 2013, which is the most complete source of differentiated 
data on healthcare expenditures. All data are in constant year 2005 terms, measured on a per 
capita basis. Private healthcare expenditures refer to the combined expenditures of all 
privately funded sources, such as private insurance payments and out-of pocket or co-
payments for treatments or medication by consumers. Public healthcare expenditures include 
both general and regional government expenditures, financed with tax revenues or social 
security funds. Finally, we gathered data on GDP per capita in constant 2005 prices (in 
national currencies) from the OECD Economic Indicator database.  
 
                                                          
3
 To ensure our cross-sectional analyses in steps 2 and 3 rely on comparable time windows, we disregarded the 
observations available prior to 1990 for a few countries in our sample. 
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Findings 
We ranked the estimated comovement elasticities of public and private healthcare 
expenditures. Figure 1 shows the mean elasticity per quartile for these ranked estimated 
comovement elasticities. 
 
--- insert Figure 1 about here--- 
 
The sign of the elasticity indicates whether healthcare expenditures behave procyclically (+) 
and move in the same direction as the economy or countercyclically (-) and move in the 
opposite direction. As we expected, Figure 1 reveals great diversity in the comovement 
elasticities across both countries and spending source (i.e., private versus public). A meta-
analysis, obtained by the method of adding weighted Zs (Rosenthal 1991), shows that private 
spending on average is procyclical (Z = 2.23; p < .05). However, we find  no unidirectional 
effect of business cycle sensitivity in the public comovement elasticities (Z = -.359;  p > .1).   
We also consider whether the elasticities of public and private expenditures within a 
country tend to move in the same direction (Table 2). More than one-third of all countries in 
the sample (37.5%) display procyclical private and public healthcare expenditures; another 
25% shows purely countercyclical behavior. In the latter situation, both private and public 
buyers invest consistently during an economic crisis, but the two types of buyers exhibit 
opposite reactions in the former case. Although somewhat less frequently, private and public 
expenditures may also exhibit contrary directions: in 12.5% (25%) of the cases, tough 
economic times prompt private consumers to spend consistently more (less) on healthcare, 
while the government uses the opportunity to save (spend) money in this sector.  
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--- insert Table 2 about here--- 
3. LONG-TERM CONSEQUENCES OF CYCLICAL SENSITIVITY 
Having established the cyclical sensitivity of the healthcare sector in section 2, we now turn to 
the long-term impact of this cyclical sensitivity on mortality rates and total healthcare 
spending.  Temporal cuts in healthcare spending might both inflate and deflate the mortality 
rate in the long run, depending on the source of the budget cuts. If certain diseases (e.g., HIV, 
schizophrenia, visual impairment) are not treated promptly, due to private budget cuts, they 
may cause irreversible harm to patients, which might lead to a long-term increase in the 
mortality rate (Hitris and Posnett 1992). Yet, public cuts in the health sector may be required 
at regular times to ensure its efficiency (see the Canadian example discussed in Liu et al. 
2001), and these cuts are easier to justify when the overall economy is struggling (Lane 
2003b). In addition, Ruhm (2000, 2003, 2005) shows that mortality rates tend to decrease 
during economic recessions (i.e., procyclical pattern),4 indicating that cuts in health 
expenditures during tough economic times are sensible. When public cost cuts during 
economic downturns indeed lead to increased efficiency in the sector, they may deflate the 
mortality rate of the overall population.  
More efficient healthcare systems also cost less money, implying that efficient public 
cost cuts during tough economic times should lead to lower long-term growth in healthcare 
expenditures. In contrast, private cost cuts during these periods may require subsequent 
overcompensation to regain the same level of healthcare that the person enjoyed prior to the 
reductions (Blanchard and Summers 1986; Fatás 2002). Procyclical reductions of private 
healthcare expenditures also might results in the postponement of less urgent treatments 
                                                          
4
 In a more recent study, Ruhm (2013) finds that the cyclical sensitivity of mortality has grown more dependent 
on the cause of death. Deaths due to cardiovascular diseases and vehicle accidents remain procyclical; deaths 
caused by cancer have become countercyclical since 2010. Our observation window ends in 2011, so we assume 
that the mortality rate has behaved procyclically for most of our observation window.  
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(Strine et al. 2008), which could increase the chances of extremely costly, urgent procedures 
later and thereby inflate overall health expenditures in the long run.  
 
Method 
To measure the long-term consequences of cyclical sensitivity, we link the comovement 
elasticities of healthcare expenditures to long-term average growth in the mortality rate 
(Equation 4) and total healthcare expenditures (Equation 5): 
 ∆݉݋ݎݐ݈ܽ�ݐݕ�௧௥௘௡ௗ =  ߛ଴ + ߛଵ̂ߚ�௣௨௕ + ߛଶ̂ߚ�௣௥� + ߛଷ∆ℎܿ݁�௧௥௘௡ௗ+ߴ�   (4), 
∆ℎܿ݁�௧௥௘௡ௗ =  ߜ଴ + ߜଵ̂ߚ�௣௨௕ + ߜଶ̂ߚ�௣௥� + ߜଷ∆݃݀݌�௧௥௘௡ௗ+ߵ�    (5). 
 �݋ݎݐ݈ܽ�ݐݕ�௧௧௥௘௡ௗ and ℎܿ݁�௧௧௥௘௡ௗ are the long-term components of the mortality rate and total 
healthcare expenditures series, respectively, for country i derived through the HP filter 
(Equation 1). We capture long-term growth by focusing on the average yearly growth rates of 
these series (i.e., ∆݉݋ݎݐ݈ܽ�ݐݕ�௧௥௘௡ௗ and  ∆ℎܿ݁�௧௥௘௡ௗ), estimated by an intercept-only regression 
on the first differences of the log-transformed trend components. 
As past research has shown that the mortality rate relates to healthcare expenditures in 
the long run (see e.g. Hitiris and Posnett 1992), we included the long-term average growth of 
total healthcare expenditures (∆ℎܿ݁�௧௥௘௡ௗ) as a control variable in Equation 4. In Equation 5, 
we also control for long-term average growth of GDP (∆݃݀݌�௧௥௘௡ௗሻ as GDP is the most 
influential factor driving long-term healthcare expenditure growth (Barros 1998; Di Matteo 
and Di Matteo 1998). This specification yields simultaneity, for which we control by applying 
a two-stage least squares procedure in Equation 4. The long-term GDP growth is an 
instrument for the endogenous long-term growth of healthcare expenditures (Gerdtham and 
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Loethgren 2000). The Cragg-Donald test statistic was significant (F(1,22) = 7.40, p < .10), so 
our instrument demonstrates sufficient strength.   
The dependent variables in Equations 4 and 5 are estimated values, with varying 
degrees of estimation accuracy. To control for potential biases in the standard error estimates, 
we used the inverse of the standard errors of the long-term average growth rates as weights in 
our estimation. In addition, we divided the estimated comovement elasticities on the right-
hand sides of Equations 4 and 5 by their standard errors, to control for estimation biases (see 
Pauwels and Hanssens 2007 for a similar practice).  
 
Data 
We obtained the per country data about the standardized number of deaths (due to internal 
causes) per 100,000 inhabitants per year from the OECD.  This variable is comparable across 
countries, because it controls for differences in age structures (OECD 2011). Dynamics in this 
value thus depict pure gains or losses in the health of a country’s population. The data on 
healthcare expenditures and GDP came from the OECD statistics, as we described in Section 
2, and the descriptives of the variables are in Table 1.  
 
Findings 
We summarize the results in Table 3. Public comovement elasticity has a significant, negative 
effect on the average long-term growth of mortality (ߛ̂ߚ�݌ݑܾ= - .0014; p  <  .05). Countries with 
greater procyclical sensitivity in public healthcare expenditures thus exhibit a lower long-term 
growth rate in mortality. However, we find no significant effect for the private comovement 
elasticity (ߛ̂ߚ�݌ݎ�= - .0002; p >  .10). We also uncover a negative relationship between the 
average long-term growth in total healthcare expenditures and average long-term growth in 
mortality (ߛ∆hce�ݐݎ݁݊݀̂  .2886; p < .10), in line with Hitris and Posnett’s (1992) findings.   
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--- insert Table 3 about here--- 
 
Although long-term growth in the mortality rate depends on the cyclical sensitivity of 
public healthcare expenditures, long-term growth in total healthcare expenditures instead is 
driven by the cyclical sensitivity of the private healthcare investments. Private comovement 
elasticity has a significant positive impact on the average long-term growth of total healthcare 
expenditures (ߜ̂ߚ�݌ݎ�=  .0019; p < .01). Public comovement elasticity, in contrast, does not have 
any impact on the long-term growth in total healthcare expenditures (ߜ̂ߚ�݌ݑܾ=  .0003; p >  .10). 
Finally, in line with Herwartz and Theilen (2003), we find that GDP growth has a significant 
positive impact on average growth in total healthcare expenditures (ߜ∆௚ௗ௣���೐�೏  =  .9683; p < 
.01). 
 
Discussion 
Procyclical fluctuations in public health expenditures drive down the growth in the mortality 
rate. Consistently cutting public health expenditures during an economic contraction (i.e., a 
procyclical strategy) improves the long-term health status of the population more than 
consistently decreasing public spending in the health sector during  economic upturns (i.e., a 
countercyclical strategy). Reductions in healthcare expenditures at regular times are necessary 
to make the healthcare sector more efficient. An economic downturn appears to offer the 
perfect opportunity to do so, because such cuts are easier to justify in tough economic 
climates (Lane 2003b). Moreover, as the rich literature stream led by Ruhm (2000, 2003, 
2005) has shown, mortality rates tend to be lower in economic downturns. When cutting 
public health expenditures is necessary for efficiency reasons, it also makes sense to do so 
when the general population’s health status tends to be better, namely in periods of economic 
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contractions. Cyclical sensitivity in private healthcare expenditures has no significant impact 
on long-term mortality rates.  
 Instead, the business cycle volatility of private expenditures influences long-term 
growth in total healthcare expenditures. When private consumers decide to economize on 
healthcare provisions during tough economic times, they postpone both urgent and less urgent 
treatments, which increases their likely need for extremely costly, urgent procedures later 
(OECD 2011).    
 
 
4. EXPLANATORY FACTORS FOR CYCLICAL SENSITIVITY 
In the previous analyses, we demonstrated the variance of cyclical sensitivity in public and 
private healthcare expenditures, as well as their long-term consequences. In this section, we 
investigate policy decisions that may explain such cross-country variability.  
Extent of private healthcare funding. Systems with more private expenditures 
allocate increased responsibility to individual consumers (Glied 2008), which reduces 
opportunities for collectivistic risk pooling. During an economic contraction, fewer people 
can afford care, which might cause private expenditures to be more procyclical. Furthermore, 
in predominantly private healthcare systems, the state has a small role in healthcare provision, 
which makes it easier for politicians to economize on the healthcare budget when economic 
times are tight (Glied 2008). This element might result in higher procyclical fluctuations of 
public expenditures.  
Social health insurance based healthcare system. A public healthcare budget might 
be collected by taxes (Beveridge system) or social health insurances (Bismarck system) 
collected from the workforce. During economic downturns, the revenues from social health 
insurances decrease, because of the higher unemployment rate. Tax-related systems instead 
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draw revenues from both taxes and nontax government revenues (Wagstaff 2009), which are 
less sensitive to the business cycle, in that they get collected from less cyclical sources (Glied 
2008). Therefore, we expect public healthcare expenditures to be more procyclical in 
countries in which the public healthcare budget relies on social health insurance revenues.5 
Public prevention budgets. Governments invest in prevention activities to improve 
their citizens’ health consciousness and the timely acquisition of treatments or preventive 
actions (OECD 2011). Such prevention campaigns increase health awareness, which might 
induce more stable health expenditures. That is, we expect that a higher level of public 
prevention expenditures decreases the procyclical sensitivity of private healthcare 
expenditures. 
Public debt. Countries with a stronger fiscal position suffer less severely in economic 
downturns (Berkmen et al. 2012). Nations with a lower debt level have fewer obligations, so 
they have more room to maneuver during economic downturns. Therefore, we expect public 
health expenditures to be less procyclical in countries with lower debt levels.    
 
Method 
To identify the explanatory factors of cyclical sensitivity, we regressed the private and public 
comovement elasticities on the previously outlined factors in a system of Equations 6 and 7: 
 ̂ߚ�௣௥� =  ߞ଴ + ߞଵܧݔݐ݁݊ݐ ݋݂ ݌ݎ�ݒܽݐ݁ ݂ݑ݊݀�݊݃� + ߞଶ�ݎ݁ݒ݁݊ݐ�݋݊ ܾݑ݀݃݁ݐ�+ ߶� (6), 
̂ߚ�௣௨௕ = ߟ଴  + ߟଵܧݔݐ݁݊ݐ ݋݂ ݌ݎ�ݒܽݐ݁ ݂ݑ݊݀�݊݃� + ߟଶ�݋ܿ�݈ܽ ℎ݈݁ܽݐℎ �݊ݏݑݎܽ݊ܿ݁ ݏݕݏݐ݁݉� 
                                                          
5
 The cyclicality of a country’s revenues may also depend on their dependency on natural resources because of 
fluctuating commodity prices. We tested whether countries whose export relied more on natural resources have a 
higher business cyclicality of the healthcare sector in an extra analysis. In line with Sachs and Warner (1997), we 
operationalize this dependency as the extent of export that comes from primary products and natural resources, 
derived from the UN Comtrade database. However, a country’s dependency on natural resources turns out to be 
unrelated to the cyclical sensitivity of both private and public health care expenditures, and therefore we decided 
to not include it in our final model. We thank an anonymous reviewer for this suggestion.   
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                          +ߟଷܦܾ݁ݐ�+߷�         (7). 
 
  ܧݔݐ݁݊ݐ ݋݂ ݌ݎ�ݒܽݐ݁ ݂ݑ݊݀�݊݃� represents the average degree to which a healthcare system is 
private, and Social health insurance systemi indicates whether the healthcare system is 
financed by social health insurance (rather than taxes). We also account for the average extent 
of preventive budgets relative to GDP   �ݎ݁ݒ݁݊ݐ�݋݊ ܾݑ݀݃݁ݐ� , whereas ܦܾ݁ݐ� indicates the 
average degree of public debt relative to GDP.   
The dependent variables, the comovement elasticities derived from Equation 3, are 
estimated values with differing degrees of estimation accuracy, so we used the standard errors 
as weights in the estimation.  Finally, we allowed for correlation between the error terms  ߶� 
and ߷� by estimating Equations 6 and 7 as a system, using seemingly unrelated regression.  
 
Data 
The extent of private funding is operationalized as the average ratio of private expenditures 
and total health expenditures over time. We account for a social health insurance system  by a 
dummy variable that equals 1 for a health system that is financed by social health insurance 
funds and 0 for systems financed by taxes (classification adopted from Wagstaff 2009). The 
prevention budget is the average annual public prevention spending relative to GDP during 
our research period, and debt is operationalized as the average public debt relative to GDP. 
We determined public debt from the OECD economic indicator database; all other variables 
came from the OECD Health Data 2012. The descriptives of these variables are included in 
Table 1.  
 
Findings 
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As we show in Table 4, the share of private expenditures related positively to cyclical 
fluctuations in private healthcare expenditures (ߞா௫௧௘௡௧ ௢௙ ௣௥�௩௔௧௘ ௙௨௡ௗ�௡௚� =  1.423; p < .05), 
whereas higher levels of prevention expenditures related negatively to the private 
comovement elasticities (ߞ�௥௘௩௘௡௧�௢௡ ௕௨ௗ௚௘௧� = -93.005; p < .10). For the comovement 
elasticities of public expenditures (Equation 7), a different picture emerged though. When 
countries’ healthcare systems rely on social health insurance, they tend to show more 
procyclical sensitivity to the business cycle than do countries with tax-based systems 
(ߟௌ௢௖�௔௟ ℎ௘௔௟௧ℎ �௡௦௨௥௔௡௖௘ ௦௬௦௧௘௠�=  0.370; p < .05). We found no significant effects of the extent 
of private healthcare expenditures (ߟா௫௧௘௡௧ ௢௙ ௣௥�௩௔௧௘ ௙௨௡ௗ�௡௚ � =   -.755; p > .10) and the 
country’s average debt level (ߟ஽௘௕௧� =  -.0004; p > .10). 
 
--- insert Table 4 about here--- 
 
Discussion 
The business cycle volatility of private healthcare expenditures is driven by the extent of 
private funding in the healthcare sector and the extent of a public prevention budget. In 
healthcare systems with greater private expenditures, the responsibility of healthcare shifts to 
the consumers (Glied 2008), and the opportunities for collectivistic pooling diminish. 
Therefore, private healthcare expenditures depend heavily on individual budgets available for 
health care. Because average consumer budgets tend to be lower in tough economic times, 
countries that depend more on private expenditures in the health sector tend to be more 
procyclical. 
 The results also show that the government has important means at its disposal to 
reduce this procyclical behavior by private buyers. Countries with higher prevention budgets 
successful mitigate cost cutting by private consumers during economic downturns. By 
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investing in prevention activities, governments can increase the population’s health awareness 
and consciousness (OECD 2011), which encourages people to refrain from cutting back on 
their healthcare during economic contractions. 
 On the public side of healthcare expenditures, a different picture emerges. The extents 
of private funding and debt have no significant effects on the business cycle sensitivity of 
public healthcare expenditures, but the manner in which the public healthcare budget gets 
collected matters. Countries that mainly rely on a Bismarck system and collect funding from 
the workforce through social health insurance, tend to be more procyclical than countries with 
tax-based (or Beveridge) systems. This finding is not surprising; social health insurance gets 
collected from workforce sources that are much more sensitive to business cycles than are 
general taxes (Glied 2008).   
 
5. CONCLUSION 
By examining the business cycle sensitivity of public and private healthcare 
expenditures in 32 countries, we find enormous diversity in how public and private healthcare 
spending relate to the business cycle. Private buyers in 62.5% of these countries economize 
on their healthcare expenditures during economic contractions, such that by switching to less 
expensive generic pharmaceuticals and postponing less urgent medical treatments (Deloitte 
2011). Yet, private healthcare expenditures instead move in the opposite direction of the 
economic business cycle in 37.5% of the countries in our sample. Economic contractions can 
lead to increases in the rates of some diseases (Stuckler et al. 2009), which might explain this 
increase in private healthcare spending during tough economic times. For the public 
component of healthcare expenditures, we find similar diversity across countries. Half of the 
governments consistently spend more during economic downturns, following a classical 
Keynesian approach that seeks to stimulate the economy by increasing public spending on 
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healthcare when the economy stumbles (Lane 2003a). The other half appear to follow the 
opposite strategy, such that when their economy goes sour, these governments feel forced to 
reduce their expenditures (Berkmen et al. 2012). An economic contraction even can offer a 
justification for reorganizing the socially delicate healthcare sector (Lane 2003b).  
In addition to these necessary insights into the cyclical sensitivity of healthcare 
expenditures, our study seeks to help policy makers establish the consequences of different 
strategies in the long term. We find that economizing on private expenditures during 
economic crises increases growth in total healthcare expenditures. By eliminating preventive 
treatment or postponing less urgent medical procedures, consumers might let diseases grow 
unchecked and thus face more expensive treatments later. Policy makers need to discourage 
such postponement behavior, whether by educating people about the underlying risk or 
temporarily reducing the out-of-pocket payments they require. In contrast, procyclical 
behavior on the public side leads to more negative growth in the country’s mortality figures 
overall. Governments thus should leverage tough economic environments to justify budget 
cuts in the healthcare sector, necessary to increase its efficiency, because ultimately they help 
improve the health status of the population.  
Finally, we provide insights into which factors influence the degree of cyclical 
sensitivity. Public prevention activities and a publicly funded healthcare system reduce the 
procyclical volatility of private healthcare expenditures. Considering the negative long-term 
consequences in terms of total healthcare expenditures, these findings suggest a stronger 
emphasis on prevention in line with recent OECD recommendations (Gurria 2011). In 
addition, our findings lend support to proponents of initiatives to broaden public healthcare 
systems, such as the U.S. Affordable Healthcare Act (popularly known as Obamacare). 
Systems that rely more on social health insurance sources have more procyclical public 
23 
 
expenditures, which deflate the mortality rate. Therefore, it appears beneficial to move from 
pure tax-based systems toward social health insurance systems.  
In summary, this article contributes to the ongoing discussion about how to maintain 
the population’s health status (low mortality rates) while also keeping healthcare expenditures 
under control. We show that, beyond the generally accepted role of GDP, cyclical behaviors 
by public and private parties in the healthcare sector have important impacts in the long run. 
Countries should seek to minimize budget cuts by private citizens but stimulate public budget 
cuts during economic contractions, by increasing prevention activities and reformulating their 
healthcare as a more publicly funded system that relies predominantly on social insurances.
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Table 1: Descriptive statistics 
                   
Series  Mean  SD  Min  Max  N 
Healthcare Expenditures              
     
 
 
    
Average per-country private 
healthcare expenditures 
relative to GDP (in%)  
2.33  1.30  0.70 
 
7.95 
 
32 
           
Average per-country public 
healthcare expenditures 
relative to GDP (in %)  
5.79  1.50  2.39 
 
8.20 
 
32 
           
Long-Term Consequences  
 
 
         
Average per-country growth 
in number of deaths*(in %)  -2.59  0.53  -4.05  -1.67 
 
31 
               
Average per-country growth 
in total health expenditures 
(in %)  
3.34 
 
1.31 
 
1.60 
 
7.60 
 
32 
 
Explanatory Factors 
 
Average per-country 
proportion of private 
healthcare expenditures in 
total healthcare expenditures 
(in %) 
 
 
28.70 
 
12.40 
 
10.27 
 
55.80 
 
32 
Social health insurance 
system (0/1) 
 
 
0.44 
 
0.50 
 
0 
 
1 
 
32 
 
Average per-country 
prevention expenditures 
relative to GDP**  
0.20 
 
0.14 
 
0.03 
 
0.68 
 
31 
 
Average per-country public 
debt relative to GDP (in %)   
47.80 
 
28.50 
 
3.37 
 
109.9 
 
32 
          
          
 
*Mortality figures unavailable for Turkey 
** Prevention figures unavailable for Chile.  
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Table 2: Distribution of comovement elasticities 
Distribution of Elasticities 
 Private Expenditures  
  Procyclical Countercyclical 
Pu
bl
ic
 E
x
pe
n
di
tu
re
s 
Pr
oc
yc
lic
al
 
Czech Republic, Hungary, Iceland, 
Greece, Israel, Italy, Korea (south), 
Luxembourg, Mexico, Portugal, 
Slovakia, Turkey 
Australia, Austria, Japan, Poland  
Co
u
n
te
rc
yc
lic
al
 
Belgium, Chile, Denmark, Finland, 
the Netherlands, Norway, U.K., U.S. 
Canada, France, Germany, Ireland, New 
Zealand, Spain, Sweden, Switzerland 
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Table 3: Long-term consequences of cyclical sensitivity 
 
 
 
 
 
 
Table 4: Explanatory factors of cyclical sensitivity 
 
 
 
 
 
  
               Dependent variable ∶  ∆mortality�௧௥௘௡ௗ     n= 31  Dependent variable: ∆hce�௧௥௘௡ௗ   n=32   
Independent Variable  Coefficient   St Error  Independent Variable  Coefficient   St   Error 
             
Intercept  -0.0157 *** 0.0050  Intercept  0.0165 *** 0.0020 ̂ߚ�௣௥�  -0.0002  0.0007  ̂ߚ�௣௥�  0.0019 *** 0.0006 ̂ߚ�௣௨௕    -0.0014 ** 0.0005  ̂ߚ�௣௨௕  0.0003  0.0007 ∆hce�௧௥௘௡ௗ  -0.2886 * 0.1675  ∆gdp�௧௥௘௡ௗ  0.9683 *** 0.1032 
R²  10.52%  R²  71.62% 
           
* p < .10, ** p < .05, *** p < .01.  
Notes: Mortality figures unavailable for Turkey. 
                Dependent variable ∶  ̂ߚ�௣௥�    n= 31  Dependent variable: ̂ߚ�௣௨௕   n=32   
Independent Variable  Coefficient   St. Error  Independent Variable  Coefficient   St. Error 
             
Intercept  -0.066  0.262  Intercept  0.052 
 
0.199 ܧݔݐ݁݊ݐ ݋݂ ݌ݎ�ݒܽݐ݁ ݂ݑ݊݀�݊ �݃   1.423 ** 0657  ܧݔݐ݁݊ݐ ݋݂ ݌ݎ�ݒܽݐ݁ ݂ݑ݊݀�݊ �݃  -0.755  0.515 �ݎ݁ݒ݁݊ݐ�݋݊ ܾݑ݀݃݁ݐ�  -93.005 * 54.803  �݋ܿ�݈ܽ ℎ݈݁ܽݐℎ �݊ݏݑݎܽ݊ܿ݁ ݏݕݏݐ݁݉� 0.370 ** 0.157 
      ܦܾ݁ݐ�  - 0.0004  0.003 
R²  18.58%  R²  20.02% 
           
* p < .10, ** p < .05, *** p < .01.  
Notes: Data on public spending on prevention is not available for Chile. 
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Figure 1: Average quartile values of the comovement elasticities 
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